Literature DB >> 12112519

Prediction of postoperative pulmonary function using perfusion magnetic resonance imaging of the lung.

Tae Iwasawa1, Kimihiko Saito, Nobuo Ogawa, Naoki Ishiwa, Hiroaki Kurihara.   

Abstract

PURPOSE: To assess semiquantitatively the regional distribution of lung perfusion using magnetic resonance (MR) perfusion imaging.
MATERIALS AND METHODS: Subjects were 20 consecutive patients with bronchogenic carcinoma, who underwent MR imaging (MRI) and radionuclide (RN) perfusion scans for preoperative evaluation. Three-dimensional (3D) images of whole lungs were obtained before and 7 seconds after bolus injection of contrast material (5 ml of Gd-DTPA). Subtraction images were constructed from these dynamic images. Lung areas enhanced with the contrast material were measured and multiplied by changes in signal intensity, summed for the whole lung, and the right-to-left lung ratios were calculated. The predicted postoperative forced expiratory volume in 1 second (FEV1) was estimated using MR and RN perfusion ratios.
RESULTS: The correlation between perfusion ratios derived from the MR and RN studies was excellent (r = 0.92). Sixteen of 20 patients underwent surgery, and 12 patients had postoperative pulmonary function tests. The predicted FEV1 derived from the MR perfusion ratio correlated well with the postoperative FEV1 in the 12 patients (r = 0.68).
CONCLUSION: Perfusion MRI is suitable for semiquantitative evaluation of regional pulmonary perfusion. Copyright 2002 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12112519     DOI: 10.1002/jmri.10121

Source DB:  PubMed          Journal:  J Magn Reson Imaging        ISSN: 1053-1807            Impact factor:   4.813


  11 in total

Review 1.  Magnetic resonance imaging in lung: a review of its potential for radiotherapy.

Authors:  Shivani Kumar; Gary Liney; Robba Rai; Lois Holloway; Daniel Moses; Shalini K Vinod
Journal:  Br J Radiol       Date:  2016-02-03       Impact factor: 3.039

Review 2.  MR imaging of the pulmonary vasculature--an update.

Authors:  Mark R Pedersen; Mark T Fisher; Edwin J R van Beek
Journal:  Eur Radiol       Date:  2006-01-04       Impact factor: 5.315

Review 3.  [MRI of pulmonary perfusion].

Authors:  C Fink; F Risse; W Semmler; S O Schoenberg; H-U Kauczor; M F Reiser
Journal:  Radiologe       Date:  2006-04       Impact factor: 0.635

Review 4.  Functional imaging: CT and MRI.

Authors:  Edwin J R van Beek; Eric A Hoffman
Journal:  Clin Chest Med       Date:  2008-03       Impact factor: 2.878

Review 5.  [Magnetic resonance imaging of pulmonary perfusion. Technical requirements and diagnostic impact].

Authors:  U I Attenberger; M Ingrisch; K Büsing; M Reiser; S O Schoenberg; C Fink
Journal:  Radiologe       Date:  2009-08       Impact factor: 0.635

6.  Quantitative computed tomography to predict postoperative FEV1 after lung cancer surgery.

Authors:  Alex Fourdrain; Florence De Dominicis; Sophie Lafitte; Jules Iquille; Flavien Prevot; Emmanuel Lorne; Julien Monconduit; Patrick Bagan; Pascal Berna
Journal:  J Thorac Dis       Date:  2017-08       Impact factor: 2.895

7.  Perfusion abnormalities in congenital and neoplastic pulmonary disease: comparison of MR perfusion and multislice CT imaging.

Authors:  Daniel T Boll; Jonathan S Lewin; Philip Young; Ernest S Siwik; Robert C Gilkeson
Journal:  Eur Radiol       Date:  2005-05-05       Impact factor: 5.315

Review 8.  Magnetic resonance imaging in precision radiation therapy for lung cancer.

Authors:  Hannah Bainbridge; Ahmed Salem; Rob H N Tijssen; Michael Dubec; Andreas Wetscherek; Corinne Van Es; Jose Belderbos; Corinne Faivre-Finn; Fiona McDonald
Journal:  Transl Lung Cancer Res       Date:  2017-12

Review 9.  [MRT of bronchial carcinomas].

Authors:  C Fink; C Plathow; M Klopp; A Schmähl; H-U Kauczor
Journal:  Radiologe       Date:  2004-05       Impact factor: 0.635

Review 10.  Modern diagnostic and therapeutic interventional radiology in lung cancer.

Authors:  Wai-Kit Lee; Eddie W F Lau; Kwang Chin; Oliver Sedlaczek; Karin Steinke
Journal:  J Thorac Dis       Date:  2013-10       Impact factor: 2.895

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.